ARGX:NASDAQ
argenx SE - ADR
US$ 912.87
arrow_downward
-0.69%(-6.34) Siku 1
US$ 930.68
arrow_upward
+1.95% (+17.81)todayKabla ya soko
Imefungwa: 5 Okt, 16:00:02 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ARGX...
Fungua
US$ 920.82
Juu
US$ 923.31
Chini
US$ 903.50
Mtaji wa soko
56.95B
Wastani wa kiasi cha mauzo
elfu 257.81
Kiasi cha mauzo ya hisa
215.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
34.68
Juu kwa wiki 52
US$ 1,072.75
Chini kwa wiki 52
US$ 661.85
EPS
US$ 26.32
Beta
0.45
Hisa za wawekezaji
62.56M
Idadi ya wafanyakazi
elfu 2
Fungua
US$ 920.82
Juu
US$ 923.31
Chini
US$ 903.50
Mtaji wa soko
56.95B
Wastani wa kiasi cha mauzo
elfu 257.81
Kiasi cha mauzo ya hisa
215.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
34.68
Juu kwa wiki 52
US$ 1,072.75
Chini kwa wiki 52
US$ 661.85
EPS
US$ 26.32
Beta
0.45
Hisa za wawekezaji
62.56M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
saa 13 zilizopita
Argenx stock gets fresh VYVGART data before Q3 results
Zacks
·
saa 18 zilizopita
BMY or ARGX: Which Is the Better Value Stock Right Now?
Yahoo Finance UK
·
saa 19 zilizopita
BMY or ARGX: Which Is the Better Value Stock Right Now?
AD HOC NEWS
·
siku 1 iliyopita
argenx presents Vyvgart data: Goldman lifts argenx stock target to EUR 982.00
Wasifu
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Kuhusu argenx SE - ADR
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 1.86
Lilianzishwa25 Apr 2008
Makao makuu-
Sekta-
Tovutiargenx.com